Clinical Trial Details

Overview

Research Study Summary

Meningitis Vaccine

Purpose

MEN ACWY Vaccine Research Study in Adolescents and Adults

A clinical study is happening right now to evaluate an investigational booster vaccination that may provide additional protection against meningococcal meningitis.

Meningococcal meningitis is a type of bacteria meningitis, which is a rare but potentially life-threatening disease that leads to inflammation of the protective membranes ("meninges") that surround the brain and spinal cord. Bacterial meningitis can progress quickly and can be fatal, sometimes within 24 hours. In some cases, it can lead to permanent brain damage, loss of limbs, loss of hearing, and other long-term effects.

Vaccine Research Study

If you are interested in learning more about this study or if you know someone else who may be interested in participating, please contact one of our sites:

Foothill Family Clinic 801-486-3021
Foothill Family Clinic South 801-365-1032
Foothill Family Clinic Draper 385-900-4077
Jordan River Family Medicine 801-676-8109

To Learn more

CW ID: 221200
Date Last Changed: December 1, 2016

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
15 to 55 Years
Overall Status
Recruiting
Facility Type
Out-Patient

Contact

J. Lewis Research, Inc.
3191 S. Valley St, Suite 211
Salt Lake City, UT 84109
Phone: 801-365-1032

View Map

Research Center Information:

J. Lewis Research, Inc.

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.